Tokyo, Japan

Yutaka Mori

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Shizuoka pref., JP (1999)
  • Mishima, JP (2001)
  • Shizuoka-ken, JP (2002)
  • Hachioji, JP (2004)
  • Kanagawa, JP (2010)
  • Tokyo, JP (2000 - 2021)

Company Filing History:


Years Active: 1999-2021

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Yutaka Mori: A Pioneer in Angiogenesis and Peptide Modification Innovations

Introduction

Yutaka Mori, hailing from Tokyo, Japan, is a notable inventor recognized for his contributions to the fields of angiogenesis and peptide modification. With a remarkable portfolio of 9 patents, Mori's innovations aim to tackle critical medical challenges, particularly in treating diseases such as critical limb ischemia.

Latest Patents

Among his latest patents is a groundbreaking compound known as Thrombospondin 1-binding peptide. This invention is significant as it promotes angiogenesis by inhibiting the function of TSP1, which is crucial in the treatment or prophylaxis of critical limb ischemia. Another notable patent is the Glyco-modified atrial natriuretic peptide, which showcases prolonged duration in blood while maintaining the ability to elevate cGMP levels. This modified peptide includes a sugar substance linked either directly or through a linker to the hANP peptide, offering exciting therapeutic possibilities.

Career Highlights

Throughout his career, Yutaka Mori has worked with reputable companies such as 3M Innovative Properties Company and Daiichi Sankyo Company, Limited. His role in these organizations has been vital in advancing research and development initiatives that focus on innovative therapeutic solutions.

Collaborations

Mori has had productive collaborations with esteemed colleagues, including Takahiro Yamaguchi and Takahiro Oshita. These partnerships have enhanced the research and development of his patented technologies, leading to significant advancements in medical treatments.

Conclusion

Yutaka Mori stands out as a distinguished inventor whose work in angiogenesis and peptide modification has opened new avenues in medical science. With his extensive patents and collaborative efforts, he continues to contribute meaningfully to innovation that addresses vital health issues worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…